Method for measuring immunogenicity of protein agent
AssigneeMogam Institute for Biomedical Research
InventorsOk Jae LIM, Duck Hyang SHIN
Life of this patent
Estimating the term…
Loading patent…
AssigneeMogam Institute for Biomedical Research
InventorsOk Jae LIM, Duck Hyang SHIN
Estimating the term…
A method for determining immunogenicity of a protein agent. The method includes constructing a library of peripheral blood mononuclear cells having various HLA-DRB1 genotypes; culturing peripheral blood mononuclear cell CD14+ monocyte-derived immature dendritic cells for each genotype in a medium containing a protein to be measured, GM-CSF, IL-4, TNF-α, IL-1β, IL-6 and PGF2 to prepare mature dendritic cells; removing CD8+ T cells from the peripheral blood mononuclear cells for each genotype to prepare CD8+ T cell-free peripheral blood mononuclear cells; co-culturing the mature dendritic cells and the CD8+ T cell-free peripheral blood mononuclear cells at a cell count ratio of approximately 1:5 to 1:20; and quantifying the CD4+ T cells proliferated by co-cultivation per genotype.
A method for determining immunogenicity of a protein agent, comprising:
A kit for measuring immunogenicity of a protein agent, comprising a library of peripheral blood mononuclear cells including 70% or more of human HLA-DRB1 genetic polymorphisms.
Dependencies are inferred from the claim text.